ResMed Inc. Lawsuit Submission Form | Class Action Lawsuit List

First Name

Last Name

Phone

Street Address

City

State

Zip

Shares Owned

Purchase Date

Estimated Loss

Class Action Lawsuit List does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

On August 3, 2023, ResMed reported results for the fourth quarter of fiscal 2023. Analysts lowered their ratings in response to ResMed’s report, citing concerns over market share and gross margins. Following ResMed’s announcements, on August 4, 2023, ResMed’s stock price fell from $219.95 per share to $179.25 per share, a decline of more than $40 per share.

Active Cases

Ticker Symbol	Company Name	Join Deadline	Join
EW	Edwards Lifesciences Corporation	December 13, 2024	Join
TD	The Toronto-Dominion Bank	December 23, 2024	Join
WOLF	Wolfspeed, Inc.	January 17, 2025	Join

ResMed Inc.

RMD

ResMed Inc. Form

Active Cases